Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions innovation and patient care
Kedrion Biopharma, a biopharmaceutical company specializing in plasma-derived therapies, announces its participation at the International Primary Immunodeficiencies Congress (IPIC) 2025, taking place in Prague, Czech Republic, from November 5-7, 2025. This year, Kedrion hosts a dedicated Satellite Symposium, “Secondary Immunodeficiencies in Hematologic Malignancies: A Growing Area of Interest,” shining a spotlight on one of the […]